top of page

“We are grateful to the Massachusetts Life Sciences Center for supporting Virex,” said Mark Grinstaff, Virex Co-Founder and Boston University Professor. “This funding will enable prototype development of an easy-to-use, low-cost, rapid response point of care test for SARS-CoV-2 based on a novel electrochemical amplification technology. Testing is a key pillar of disease containment in the COVID pandemic. Virex’s goal is to enable widespread testing in all settings of daily life – homes, workplaces, schools, public spaces – in Massachusetts, across the United States and globally.”



bottom of page